The Library
Browse by Warwick Author
Up a level |
Jump to: Advanced Encryption Standard | Algeta and Bayer HealthCare Pharmaceuticals | Astellas | AstraZeneca (Firm) | Birmingham Experimental Cancer Medicine Centre | Birmingham Science City | Boehringer Ingelheim Pharmaceuticals | British Mycological Society (BMS) | Cancer Research UK (CRUK) | Celgene (Firm) | Comunità Autonoma di Madrid | European School of Oncology | European Union (EU) | GlaxoSmithKline | Great Britain. Department of Health (DoH) | Günter and Regine Kelm Foundation | Janssen (Firm) | Janssen Pharmaceutical Ltd. | KWF Kankerbestrijding [Dutch Cancer Society] | Kantonsspital St. Gallen | Medical Research Council (Great Britain) (MRC) | National Cancer Research Institute (NCRI) | National Institute for Health Research (Great Britain) (NIHR) | North Staffordshire Medical Institute | Novartis (Firm) | Pfizer Inc. | Pierre Fabre Laboratories | Prostate Cancer Foundation | Pfizer Ltd. | Royal Surrey County Hospital Trust | Saint Gall (Switzerland : Canton) | Sanofi Aventis (Firm) | Schweizerische Arbeitsgruppe für Klinische Krebsforschung (SAKK) | Schweizerische Krebsliga | Seventh Framework Programme (European Commission) (FP7) | Swiss Cancer Foundation | Swiss Cancer Research Organisation | The University Hospital of North Midlands NHS Trust Cancer Charitable Foundation | University Hospitals Birmingham NHS Foundation Trust | University of Birmingham | University of Leeds | University of Surrey | Urology Foundation | Wellcome Trust (London, England)
Number of items: 63.
Advanced Encryption Standard
Feber, Andrew, Dhami, Pawan, Dong, Liqin, de Winter, Patricia, Tan, Wei Shen, Martínez-Fernández, Mónica, Paul, Dirk S., Hynes-Allen, Antony, Rezaee, Sheida, Gurung, Pratik et al.
(2017)
UroMark—a urinary biomarker assay for the detection of bladder cancer.
Clinical Epigenetics, 9
(1).
8.
doi:10.1186/s13148-016-0303-5
ISSN 1868-7075.
Algeta and Bayer HealthCare Pharmaceuticals
Parker, C., Nilsson, S., Heinrich, Daniel, Helle, Svein I., O'Sullivan, J. M., Fosså, Sophie D., Chodacki, Aleš, Wiechno, Paweł, Logue, John, Seke, M. et al.
(2013)
Alpha emitter radium-223 and survival in metastatic prostate cancer.
The New England Journal of Medicine, 369
(3).
pp. 213-223.
doi:10.1056/NEJMoa1213755
ISSN 0028-4793.
Astellas
James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., De Bono, Johann S., Gale, Joanna, Hetherington, John, Hoskin, Peter J., Jones, Robert J., Laing, Robert et al.
(2014)
Survival with newly diagnosed metastatic prostate cancer in the “Docetaxel era” : data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019).
European Urology, 67
(6).
pp. 1028-1038.
doi:10.1016/j.eururo.2014.09.032
ISSN 0302-2838.
AstraZeneca (Firm)
Pond, Gregory R., Agarwal, Neeraj, Bellmunt, Joaquim, Choueiri, Toni K., Qu, Angela, Fougeray, Ronan, Vaughn, David, James, Nicholas D., Salhi, Yacine, Albers, Peter et al.
(2014)
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
BJU International, 113
(5b).
E137-E143.
doi:10.1111/bju.12564
ISSN 1464-1603.
Sonpavde, Guru, Pond, Gregory R., Fougeray, Ronan, Choueiri, Toni K. , Qu, Angela, Vaughn, David, Niegisch, Günter, Albers, Peter, James, Nicholas D., Wong, Yu-Ning et al.
(2013)
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma : a retrospective analysis of pooled, prospective phase 2 trials.
European Urology, 63
(4).
pp. 717-723.
doi:10.1016/j.eururo.2012.11.042
ISSN 0302-2838.
Birmingham Experimental Cancer Medicine Centre
Kitchen, Mark O., Bryan, Richard T., Haworth, Kim E., Emes, Richard D., Luscombe, Christopher, Gommersall, Lyndon, Cheng, Kar K., Zeegers, Maurice P., James, Nicholas D., Devall, Adam J., Fryer, Anthony A. and Farrell, William E. (2015) Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer. PLoS One, 10 (9). pp. 1-12. e0137003. doi:10.1371/journal.pone.0137003 ISSN 1932-6203.
Birmingham Science City
Morgan, Richard, Bryan, Richard T., Javed, Saqib, Launchberry, Francesca, Zeegers, Maurice, Cheng, Kar K. , James, Nicholas D., Wallace, Michael A., Hurst, Carolyn D., Ward, Douglas G., Knowles, Margaret A. and Pandha, Hardev (2013) Expression of engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer, 49 (9). pp. 2214-2222. doi:10.1016/j.ejca.2013.01.019 ISSN 0959-8049.
Boehringer Ingelheim Pharmaceuticals
Pond, Gregory R., Agarwal, Neeraj, Bellmunt, Joaquim, Choueiri, Toni K., Qu, Angela, Fougeray, Ronan, Vaughn, David, James, Nicholas D., Salhi, Yacine, Albers, Peter et al.
(2014)
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
BJU International, 113
(5b).
E137-E143.
doi:10.1111/bju.12564
ISSN 1464-1603.
Sonpavde, Guru, Pond, Gregory R., Fougeray, Ronan, Choueiri, Toni K. , Qu, Angela, Vaughn, David, Niegisch, Günter, Albers, Peter, James, Nicholas D., Wong, Yu-Ning et al.
(2013)
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma : a retrospective analysis of pooled, prospective phase 2 trials.
European Urology, 63
(4).
pp. 717-723.
doi:10.1016/j.eururo.2012.11.042
ISSN 0302-2838.
British Mycological Society (BMS)
Pond, Gregory R., Agarwal, Neeraj, Bellmunt, Joaquim, Choueiri, Toni K., Qu, Angela, Fougeray, Ronan, Vaughn, David, James, Nicholas D., Salhi, Yacine, Albers, Peter et al.
(2014)
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
BJU International, 113
(5b).
E137-E143.
doi:10.1111/bju.12564
ISSN 1464-1603.
Sonpavde, Guru, Pond, Gregory R., Fougeray, Ronan, Choueiri, Toni K. , Qu, Angela, Vaughn, David, Niegisch, Günter, Albers, Peter, James, Nicholas D., Wong, Yu-Ning et al.
(2013)
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma : a retrospective analysis of pooled, prospective phase 2 trials.
European Urology, 63
(4).
pp. 717-723.
doi:10.1016/j.eururo.2012.11.042
ISSN 0302-2838.
Cancer Research UK (CRUK)
Real, Francisco X., Ward, Douglas G., Baxter, Laura, Gordon, Naheema S., Ott, Sascha, Savage, Richard S., Beggs, Andrew D., James, Jonathan D., Lickiss, Jennifer, Green, Shaun, Wallis, Yvonne, Wei, Wenbin, James, Nicholas D., Zeegers, Maurice P., Cheng, K. K., Mathews, Glenn M., Patel, Prashant, Griffiths, Michael and Bryan, Richard T. (2016) Multiplex PCR and next generation sequencing for the non-invasive detection of bladder cancer. PLoS One, 11 (2). pp. 1-11. e0149756. doi:10.1371/journal.pone.0149756 ISSN 1932-6203.
Kitchen, Mark O., Bryan, Richard T., Haworth, Kim E., Emes, Richard D., Luscombe, Christopher, Gommersall, Lyndon, Cheng, Kar K., Zeegers, Maurice P., James, Nicholas D., Devall, Adam J., Fryer, Anthony A. and Farrell, William E. (2015) Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer. PLoS One, 10 (9). pp. 1-12. e0137003. doi:10.1371/journal.pone.0137003 ISSN 1932-6203.
James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., De Bono, Johann S., Gale, Joanna, Hetherington, John, Hoskin, Peter J., Jones, Robert J., Laing, Robert et al.
(2014)
Survival with newly diagnosed metastatic prostate cancer in the “Docetaxel era” : data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019).
European Urology, 67
(6).
pp. 1028-1038.
doi:10.1016/j.eururo.2014.09.032
ISSN 0302-2838.
van Roekel, Eline H., Cheng, Kar K., James, Nicholas D., Wallace, D. Michael, Billingham, Lucinda J., Murray, Paul G., Bryan, Richard T. and Zeegers, Maurice P. (2013) Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumours at diagnosis. International Journal of Cancer, 133 (2). pp. 446-454. doi:10.1002/ijc.28017 ISSN 0020-7136.
Morgan, Richard, Bryan, Richard T., Javed, Saqib, Launchberry, Francesca, Zeegers, Maurice, Cheng, Kar K. , James, Nicholas D., Wallace, Michael A., Hurst, Carolyn D., Ward, Douglas G., Knowles, Margaret A. and Pandha, Hardev (2013) Expression of engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer, 49 (9). pp. 2214-2222. doi:10.1016/j.ejca.2013.01.019 ISSN 0959-8049.
Parker, Christopher C., Sydes, Matthew R., Mason, Malcolm D., Clarke, Noel W., Aebersold, Daniel, De Bono, Johann S., Dearnaley, David P., Ritchie, A. W. S., Russell, J. Martin, Thalmann, George, Parmar, Mahesh K. B. and James, Nicholas D. (2013) Prostate radiotherapy for men with metastatic disease : a new comparison in the systemic therapy in advancing or metastatic prostate cancer : evaluation of drug efficacy (STAMPEDE) trial. BJU International, 111 (5). pp. 697-699. doi:10.1111/bju.12087 ISSN 1464-1603.
Celgene (Firm)
Pond, Gregory R., Agarwal, Neeraj, Bellmunt, Joaquim, Choueiri, Toni K., Qu, Angela, Fougeray, Ronan, Vaughn, David, James, Nicholas D., Salhi, Yacine, Albers, Peter et al.
(2014)
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
BJU International, 113
(5b).
E137-E143.
doi:10.1111/bju.12564
ISSN 1464-1603.
Comunità Autonoma di Madrid
Feber, Andrew, Dhami, Pawan, Dong, Liqin, de Winter, Patricia, Tan, Wei Shen, Martínez-Fernández, Mónica, Paul, Dirk S., Hynes-Allen, Antony, Rezaee, Sheida, Gurung, Pratik et al.
(2017)
UroMark—a urinary biomarker assay for the detection of bladder cancer.
Clinical Epigenetics, 9
(1).
8.
doi:10.1186/s13148-016-0303-5
ISSN 1868-7075.
European School of Oncology
Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R. et al.
(2015)
Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology, 26
(8).
pp. 1589-1604.
doi:10.1093/annonc/mdv257
ISSN 0923-7534.
European Union (EU)
van Roekel, Eline H., Cheng, Kar K., James, Nicholas D., Wallace, D. Michael, Billingham, Lucinda J., Murray, Paul G., Bryan, Richard T. and Zeegers, Maurice P. (2013) Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumours at diagnosis. International Journal of Cancer, 133 (2). pp. 446-454. doi:10.1002/ijc.28017 ISSN 0020-7136.
GlaxoSmithKline
Pond, Gregory R., Agarwal, Neeraj, Bellmunt, Joaquim, Choueiri, Toni K., Qu, Angela, Fougeray, Ronan, Vaughn, David, James, Nicholas D., Salhi, Yacine, Albers, Peter et al.
(2014)
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
BJU International, 113
(5b).
E137-E143.
doi:10.1111/bju.12564
ISSN 1464-1603.
Sonpavde, Guru, Pond, Gregory R., Fougeray, Ronan, Choueiri, Toni K. , Qu, Angela, Vaughn, David, Niegisch, Günter, Albers, Peter, James, Nicholas D., Wong, Yu-Ning et al.
(2013)
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma : a retrospective analysis of pooled, prospective phase 2 trials.
European Urology, 63
(4).
pp. 717-723.
doi:10.1016/j.eururo.2012.11.042
ISSN 0302-2838.
Great Britain. Department of Health (DoH)
van Roekel, Eline H., Cheng, Kar K., James, Nicholas D., Wallace, D. Michael, Billingham, Lucinda J., Murray, Paul G., Bryan, Richard T. and Zeegers, Maurice P. (2013) Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumours at diagnosis. International Journal of Cancer, 133 (2). pp. 446-454. doi:10.1002/ijc.28017 ISSN 0020-7136.
Günter and Regine Kelm Foundation
Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R. et al.
(2015)
Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology, 26
(8).
pp. 1589-1604.
doi:10.1093/annonc/mdv257
ISSN 0923-7534.
Janssen (Firm)
James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., De Bono, Johann S., Gale, Joanna, Hetherington, John, Hoskin, Peter J., Jones, Robert J., Laing, Robert et al.
(2014)
Survival with newly diagnosed metastatic prostate cancer in the “Docetaxel era” : data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019).
European Urology, 67
(6).
pp. 1028-1038.
doi:10.1016/j.eururo.2014.09.032
ISSN 0302-2838.
Janssen Pharmaceutical Ltd.
Parker, Christopher C., Sydes, Matthew R., Mason, Malcolm D., Clarke, Noel W., Aebersold, Daniel, De Bono, Johann S., Dearnaley, David P., Ritchie, A. W. S., Russell, J. Martin, Thalmann, George, Parmar, Mahesh K. B. and James, Nicholas D. (2013) Prostate radiotherapy for men with metastatic disease : a new comparison in the systemic therapy in advancing or metastatic prostate cancer : evaluation of drug efficacy (STAMPEDE) trial. BJU International, 111 (5). pp. 697-699. doi:10.1111/bju.12087 ISSN 1464-1603.
KWF Kankerbestrijding [Dutch Cancer Society]
van Roekel, Eline H., Cheng, Kar K., James, Nicholas D., Wallace, D. Michael, Billingham, Lucinda J., Murray, Paul G., Bryan, Richard T. and Zeegers, Maurice P. (2013) Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumours at diagnosis. International Journal of Cancer, 133 (2). pp. 446-454. doi:10.1002/ijc.28017 ISSN 0020-7136.
Kantonsspital St. Gallen
Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R. et al.
(2015)
Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology, 26
(8).
pp. 1589-1604.
doi:10.1093/annonc/mdv257
ISSN 0923-7534.
Medical Research Council (Great Britain) (MRC)
Feber, Andrew, Dhami, Pawan, Dong, Liqin, de Winter, Patricia, Tan, Wei Shen, Martínez-Fernández, Mónica, Paul, Dirk S., Hynes-Allen, Antony, Rezaee, Sheida, Gurung, Pratik et al.
(2017)
UroMark—a urinary biomarker assay for the detection of bladder cancer.
Clinical Epigenetics, 9
(1).
8.
doi:10.1186/s13148-016-0303-5
ISSN 1868-7075.
Vale, Claire L., Burdett, Sarah, Rydzewska, Larysa H. M., Albiges, Laurence, Clarke, Noel W., Fisher, David, Fizazi, Karim, Gravis, Gwenaelle, James, Nicholas D., Mason, Malcolm D., Parmar, Mahesh K. B., Sweeney, Christopher J., Sydes, Matthew R., Tombal, Bertrand and Tierney, Jayne F. (2016) Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer : a systematic review and meta-analyses of aggregate data. The Lancet Oncology, 17 (2). pp. 243-256. doi:10.1016/S1470-2045(15)00489-1 ISSN 1470-2045.
James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., De Bono, Johann S., Gale, Joanna, Hetherington, John, Hoskin, Peter J., Jones, Robert J., Laing, Robert et al.
(2014)
Survival with newly diagnosed metastatic prostate cancer in the “Docetaxel era” : data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019).
European Urology, 67
(6).
pp. 1028-1038.
doi:10.1016/j.eururo.2014.09.032
ISSN 0302-2838.
Parker, Christopher C., Sydes, Matthew R., Mason, Malcolm D., Clarke, Noel W., Aebersold, Daniel, De Bono, Johann S., Dearnaley, David P., Ritchie, A. W. S., Russell, J. Martin, Thalmann, George, Parmar, Mahesh K. B. and James, Nicholas D. (2013) Prostate radiotherapy for men with metastatic disease : a new comparison in the systemic therapy in advancing or metastatic prostate cancer : evaluation of drug efficacy (STAMPEDE) trial. BJU International, 111 (5). pp. 697-699. doi:10.1111/bju.12087 ISSN 1464-1603.
National Cancer Research Institute (NCRI)
Parker, Christopher C., Sydes, Matthew R., Mason, Malcolm D., Clarke, Noel W., Aebersold, Daniel, De Bono, Johann S., Dearnaley, David P., Ritchie, A. W. S., Russell, J. Martin, Thalmann, George, Parmar, Mahesh K. B. and James, Nicholas D. (2013) Prostate radiotherapy for men with metastatic disease : a new comparison in the systemic therapy in advancing or metastatic prostate cancer : evaluation of drug efficacy (STAMPEDE) trial. BJU International, 111 (5). pp. 697-699. doi:10.1111/bju.12087 ISSN 1464-1603.
National Institute for Health Research (Great Britain) (NIHR)
van Roekel, Eline H., Cheng, Kar K., James, Nicholas D., Wallace, D. Michael, Billingham, Lucinda J., Murray, Paul G., Bryan, Richard T. and Zeegers, Maurice P. (2013) Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumours at diagnosis. International Journal of Cancer, 133 (2). pp. 446-454. doi:10.1002/ijc.28017 ISSN 0020-7136.
North Staffordshire Medical Institute
Kitchen, Mark O., Bryan, Richard T., Haworth, Kim E., Emes, Richard D., Luscombe, Christopher, Gommersall, Lyndon, Cheng, Kar K., Zeegers, Maurice P., James, Nicholas D., Devall, Adam J., Fryer, Anthony A. and Farrell, William E. (2015) Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer. PLoS One, 10 (9). pp. 1-12. e0137003. doi:10.1371/journal.pone.0137003 ISSN 1932-6203.
Novartis (Firm)
James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., De Bono, Johann S., Gale, Joanna, Hetherington, John, Hoskin, Peter J., Jones, Robert J., Laing, Robert et al.
(2014)
Survival with newly diagnosed metastatic prostate cancer in the “Docetaxel era” : data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019).
European Urology, 67
(6).
pp. 1028-1038.
doi:10.1016/j.eururo.2014.09.032
ISSN 0302-2838.
Parker, Christopher C., Sydes, Matthew R., Mason, Malcolm D., Clarke, Noel W., Aebersold, Daniel, De Bono, Johann S., Dearnaley, David P., Ritchie, A. W. S., Russell, J. Martin, Thalmann, George, Parmar, Mahesh K. B. and James, Nicholas D. (2013) Prostate radiotherapy for men with metastatic disease : a new comparison in the systemic therapy in advancing or metastatic prostate cancer : evaluation of drug efficacy (STAMPEDE) trial. BJU International, 111 (5). pp. 697-699. doi:10.1111/bju.12087 ISSN 1464-1603.
Pfizer Inc.
James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., De Bono, Johann S., Gale, Joanna, Hetherington, John, Hoskin, Peter J., Jones, Robert J., Laing, Robert et al.
(2014)
Survival with newly diagnosed metastatic prostate cancer in the “Docetaxel era” : data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019).
European Urology, 67
(6).
pp. 1028-1038.
doi:10.1016/j.eururo.2014.09.032
ISSN 0302-2838.
Pierre Fabre Laboratories
Pond, Gregory R., Agarwal, Neeraj, Bellmunt, Joaquim, Choueiri, Toni K., Qu, Angela, Fougeray, Ronan, Vaughn, David, James, Nicholas D., Salhi, Yacine, Albers, Peter et al.
(2014)
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
BJU International, 113
(5b).
E137-E143.
doi:10.1111/bju.12564
ISSN 1464-1603.
Prostate Cancer Foundation
Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R. et al.
(2015)
Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology, 26
(8).
pp. 1589-1604.
doi:10.1093/annonc/mdv257
ISSN 0923-7534.
Pfizer Ltd.
Parker, Christopher C., Sydes, Matthew R., Mason, Malcolm D., Clarke, Noel W., Aebersold, Daniel, De Bono, Johann S., Dearnaley, David P., Ritchie, A. W. S., Russell, J. Martin, Thalmann, George, Parmar, Mahesh K. B. and James, Nicholas D. (2013) Prostate radiotherapy for men with metastatic disease : a new comparison in the systemic therapy in advancing or metastatic prostate cancer : evaluation of drug efficacy (STAMPEDE) trial. BJU International, 111 (5). pp. 697-699. doi:10.1111/bju.12087 ISSN 1464-1603.
Royal Surrey County Hospital Trust
Morgan, Richard, Bryan, Richard T., Javed, Saqib, Launchberry, Francesca, Zeegers, Maurice, Cheng, Kar K. , James, Nicholas D., Wallace, Michael A., Hurst, Carolyn D., Ward, Douglas G., Knowles, Margaret A. and Pandha, Hardev (2013) Expression of engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer, 49 (9). pp. 2214-2222. doi:10.1016/j.ejca.2013.01.019 ISSN 0959-8049.
Saint Gall (Switzerland : Canton)
Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R. et al.
(2015)
Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology, 26
(8).
pp. 1589-1604.
doi:10.1093/annonc/mdv257
ISSN 0923-7534.
Sanofi Aventis (Firm)
James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., De Bono, Johann S., Gale, Joanna, Hetherington, John, Hoskin, Peter J., Jones, Robert J., Laing, Robert et al.
(2014)
Survival with newly diagnosed metastatic prostate cancer in the “Docetaxel era” : data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019).
European Urology, 67
(6).
pp. 1028-1038.
doi:10.1016/j.eururo.2014.09.032
ISSN 0302-2838.
Parker, Christopher C., Sydes, Matthew R., Mason, Malcolm D., Clarke, Noel W., Aebersold, Daniel, De Bono, Johann S., Dearnaley, David P., Ritchie, A. W. S., Russell, J. Martin, Thalmann, George, Parmar, Mahesh K. B. and James, Nicholas D. (2013) Prostate radiotherapy for men with metastatic disease : a new comparison in the systemic therapy in advancing or metastatic prostate cancer : evaluation of drug efficacy (STAMPEDE) trial. BJU International, 111 (5). pp. 697-699. doi:10.1111/bju.12087 ISSN 1464-1603.
Schweizerische Arbeitsgruppe für Klinische Krebsforschung (SAKK)
Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R. et al.
(2015)
Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology, 26
(8).
pp. 1589-1604.
doi:10.1093/annonc/mdv257
ISSN 0923-7534.
Schweizerische Krebsliga
Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R. et al.
(2015)
Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology, 26
(8).
pp. 1589-1604.
doi:10.1093/annonc/mdv257
ISSN 0923-7534.
Seventh Framework Programme (European Commission) (FP7)
Feber, Andrew, Dhami, Pawan, Dong, Liqin, de Winter, Patricia, Tan, Wei Shen, Martínez-Fernández, Mónica, Paul, Dirk S., Hynes-Allen, Antony, Rezaee, Sheida, Gurung, Pratik et al.
(2017)
UroMark—a urinary biomarker assay for the detection of bladder cancer.
Clinical Epigenetics, 9
(1).
8.
doi:10.1186/s13148-016-0303-5
ISSN 1868-7075.
Swiss Cancer Foundation
Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R. et al.
(2015)
Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology, 26
(8).
pp. 1589-1604.
doi:10.1093/annonc/mdv257
ISSN 0923-7534.
Swiss Cancer Research Organisation
Gillessen, S., Omlin, A., Attard, G., de Bono, Johann S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R. et al.
(2015)
Management of patients with advanced prostate cancer : recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology, 26
(8).
pp. 1589-1604.
doi:10.1093/annonc/mdv257
ISSN 0923-7534.
The University Hospital of North Midlands NHS Trust Cancer Charitable Foundation
Kitchen, Mark O., Bryan, Richard T., Haworth, Kim E., Emes, Richard D., Luscombe, Christopher, Gommersall, Lyndon, Cheng, Kar K., Zeegers, Maurice P., James, Nicholas D., Devall, Adam J., Fryer, Anthony A. and Farrell, William E. (2015) Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer. PLoS One, 10 (9). pp. 1-12. e0137003. doi:10.1371/journal.pone.0137003 ISSN 1932-6203.
University Hospitals Birmingham NHS Foundation Trust
van Roekel, Eline H., Cheng, Kar K., James, Nicholas D., Wallace, D. Michael, Billingham, Lucinda J., Murray, Paul G., Bryan, Richard T. and Zeegers, Maurice P. (2013) Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumours at diagnosis. International Journal of Cancer, 133 (2). pp. 446-454. doi:10.1002/ijc.28017 ISSN 0020-7136.
Morgan, Richard, Bryan, Richard T., Javed, Saqib, Launchberry, Francesca, Zeegers, Maurice, Cheng, Kar K. , James, Nicholas D., Wallace, Michael A., Hurst, Carolyn D., Ward, Douglas G., Knowles, Margaret A. and Pandha, Hardev (2013) Expression of engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer, 49 (9). pp. 2214-2222. doi:10.1016/j.ejca.2013.01.019 ISSN 0959-8049.
University of Birmingham
Real, Francisco X., Ward, Douglas G., Baxter, Laura, Gordon, Naheema S., Ott, Sascha, Savage, Richard S., Beggs, Andrew D., James, Jonathan D., Lickiss, Jennifer, Green, Shaun, Wallis, Yvonne, Wei, Wenbin, James, Nicholas D., Zeegers, Maurice P., Cheng, K. K., Mathews, Glenn M., Patel, Prashant, Griffiths, Michael and Bryan, Richard T. (2016) Multiplex PCR and next generation sequencing for the non-invasive detection of bladder cancer. PLoS One, 11 (2). pp. 1-11. e0149756. doi:10.1371/journal.pone.0149756 ISSN 1932-6203.
Kitchen, Mark O., Bryan, Richard T., Haworth, Kim E., Emes, Richard D., Luscombe, Christopher, Gommersall, Lyndon, Cheng, Kar K., Zeegers, Maurice P., James, Nicholas D., Devall, Adam J., Fryer, Anthony A. and Farrell, William E. (2015) Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer. PLoS One, 10 (9). pp. 1-12. e0137003. doi:10.1371/journal.pone.0137003 ISSN 1932-6203.
van Roekel, Eline H., Cheng, Kar K., James, Nicholas D., Wallace, D. Michael, Billingham, Lucinda J., Murray, Paul G., Bryan, Richard T. and Zeegers, Maurice P. (2013) Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumours at diagnosis. International Journal of Cancer, 133 (2). pp. 446-454. doi:10.1002/ijc.28017 ISSN 0020-7136.
Morgan, Richard, Bryan, Richard T., Javed, Saqib, Launchberry, Francesca, Zeegers, Maurice, Cheng, Kar K. , James, Nicholas D., Wallace, Michael A., Hurst, Carolyn D., Ward, Douglas G., Knowles, Margaret A. and Pandha, Hardev (2013) Expression of engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer, 49 (9). pp. 2214-2222. doi:10.1016/j.ejca.2013.01.019 ISSN 0959-8049.
University of Leeds
Morgan, Richard, Bryan, Richard T., Javed, Saqib, Launchberry, Francesca, Zeegers, Maurice, Cheng, Kar K. , James, Nicholas D., Wallace, Michael A., Hurst, Carolyn D., Ward, Douglas G., Knowles, Margaret A. and Pandha, Hardev (2013) Expression of engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer, 49 (9). pp. 2214-2222. doi:10.1016/j.ejca.2013.01.019 ISSN 0959-8049.
University of Surrey
Morgan, Richard, Bryan, Richard T., Javed, Saqib, Launchberry, Francesca, Zeegers, Maurice, Cheng, Kar K. , James, Nicholas D., Wallace, Michael A., Hurst, Carolyn D., Ward, Douglas G., Knowles, Margaret A. and Pandha, Hardev (2013) Expression of engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer, 49 (9). pp. 2214-2222. doi:10.1016/j.ejca.2013.01.019 ISSN 0959-8049.
Urology Foundation
Feber, Andrew, Dhami, Pawan, Dong, Liqin, de Winter, Patricia, Tan, Wei Shen, Martínez-Fernández, Mónica, Paul, Dirk S., Hynes-Allen, Antony, Rezaee, Sheida, Gurung, Pratik et al.
(2017)
UroMark—a urinary biomarker assay for the detection of bladder cancer.
Clinical Epigenetics, 9
(1).
8.
doi:10.1186/s13148-016-0303-5
ISSN 1868-7075.
Wellcome Trust (London, England)
Feber, Andrew, Dhami, Pawan, Dong, Liqin, de Winter, Patricia, Tan, Wei Shen, Martínez-Fernández, Mónica, Paul, Dirk S., Hynes-Allen, Antony, Rezaee, Sheida, Gurung, Pratik et al.
(2017)
UroMark—a urinary biomarker assay for the detection of bladder cancer.
Clinical Epigenetics, 9
(1).
8.
doi:10.1186/s13148-016-0303-5
ISSN 1868-7075.
Real, Francisco X., Ward, Douglas G., Baxter, Laura, Gordon, Naheema S., Ott, Sascha, Savage, Richard S., Beggs, Andrew D., James, Jonathan D., Lickiss, Jennifer, Green, Shaun, Wallis, Yvonne, Wei, Wenbin, James, Nicholas D., Zeegers, Maurice P., Cheng, K. K., Mathews, Glenn M., Patel, Prashant, Griffiths, Michael and Bryan, Richard T. (2016) Multiplex PCR and next generation sequencing for the non-invasive detection of bladder cancer. PLoS One, 11 (2). pp. 1-11. e0149756. doi:10.1371/journal.pone.0149756 ISSN 1932-6203.
This list was generated on Thu Apr 25 05:50:42 2024 BST.